Spearhead Capital Advisors, LLC Veracyte, Inc. Transaction History

Spearhead Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$44.47 - $81.38 $383,553 - $701,902	-8,625 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$32.49 - $61.88 $5,230 - $9,962	161 Added 1.9%	8,625 $422,000
Q3 2020 Oct 16, 2020	BUY	$26.73 - $35.67 $16,492 - $22,008	617 Added 7.86%	8,464 $275,000
Q2 2020 Jul 16, 2020	BUY	$19.49 - $28.11 $152,938 - $220,579	7,847 New	7,847 $203,000

311

81.5M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.15B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.